Instead, at metastatic sites, TAMs secrete interleukin-35 (IL-35) to activate the JAK2–STAT6–GATA3 signaling axis in cancer cells, which reverses EMT to facilitate tissue colonization by cancer cells [94]. The gene discussed is JAK2; the disease is cancer.